Search results

Since taking power in July 1994, the RPF government has strived to eliminate the Hutu/Tutsi identities from public discourse, replacing the previous divisive identities with a unified nationalist one. For those who use Hutu/Tutsi identities outside the context of the genocide, they are considered genocidaire sympathisers, negationists and spreading divisionism. However, within the context of the genocide, the role of “ethnicity” is being reinforced and reaffirming ethnic divisions. In 2008, the Rwandan parliament officially changed the 1994 Rwandan genocide to the 1994 genocide against the Tutsi. Based on ethnographic data collected from March until October 2008, this paper will argue that within the public discourse on the genocide, the victim/perpetrator dichotomy has become intertwined with the Tutsi/Hutu identities, creating a hierarchy of victimhood. It will explore how through the process of reconciliation and in particular through gacaca the Hutu and Tutsi identities are imbued with collective guilt and victimization.

Cryptomarkets have expanded rapidly since the launch of Silk Road in 2011, offering a significant new mode for the sale and distribution of illicit drugs. One of the key questions accompanying the proliferation of cryptomarkets and online drug distribution concerns how these unique online fora alter relationships between drug suppliers and their customers. Existing research points to an increase in perceptions of safety and respect among people who use cryptomarkets to purchase drugs relative to other ‘offline’ modes of drug acquisition. There is a growing body of evidence that suggests that drug suppliers are also attracted to cryptomarkets by perceptions of increased safety, as well as by market norms and institutional processes that are characterised by respect and courteous engagement. These issues fall broadly under what has been termed market ‘gentrification’ – that is, the substitution of offline drug market norms, which are sometimes characterised by violence, intimidation, suspicion, and exploitation, with relative feelings of safety, respect, and courtesy. This chapter explores the ‘gentrification hypothesis’ and examines how the unique structural characteristics of cryptomarkets, which include user feedback and ratings, dispute resolution systems, and administrator and community ‘policing’ of cryptomarkets, as well as online discussion forums, assist in fostering the development of pro-social norms that appear to be prevalent on cryptomarkets.

This chapter explores the disruptive potential of the Internet to transform illicit drug markets while also challenging stereotypical depictions and superficial understandings of supply and demand. It argues that the digital transformation of illicit drug markets combines, on one hand, a reconfiguration of the scope and impact of how sellers, buyers, and other actors interact within and upon digitally mediated retail drug markets and, on the other hand, continuing trends in the embeddedness of market structures in cultural, economic, political, and legal realms. We develop conceptual ideas for studying the architecture of digital drug markets by drawing on interdisciplinary approaches to digitalisation, markets, and drugs. To understand the functioning of online drug markets, we first need to understand digitalisation. Thus, we draw on scholarship on the digital transformation of society and, second, put forward an understanding of markets that considers how personal relations and social structures enhance and restrict market exchange. Thus, we draw on economic sociology. Third, we build on and extend social science research on illicit drug markets which points out that drug markets exhibit significant variations over time and across jurisdictions. The introduction aims to provide a research agenda that can help us to explore ongoing digital transformations of illicit drug markets. It expands and deepens scholarship on the technological, structural, economic, and cultural factors underlying the resilience and growth of digital drug markets. It also goes beyond a concern with just one type of digital drug market into wider forms of digital environments.